Down-regulation of Wee1 Kinase by a Specific Subset of MicroRNA in Human Sporadic Pituitary Adenomas
Overview
Authors
Affiliations
Context: The tumorigenic mechanisms involved in pituitary adenomas, especially of nonfunctional pituitary adenomas (NFAs), remains unclear. Various cell cycle inhibitors have been found to be underexpressed in pituitary tumors; however, Wee1 kinase, a nuclear protein that delays mitosis and was recently recognized as a tumor suppressor gene, has not been previously investigated in pituitary tumors.
Objective: Our objective was to examine the expression of Wee1 in pituitary tumors and to identify microRNAs (miRs) that can regulate its expression.
Design: Expression of Wee1 was examined by immunohistochemistry and quantitative real-time PCR (qRT-PCR). Identification of miRs targeting the Wee1 3'-untranslated region was performed by miR array followed by expression analysis of identified miRs using qRT-PCR. Dual-luciferase assay and transient transfection of miRs into Hela cells followed by immunoblot analysis of Wee1 protein and cell proliferation analysis were carried out.
Patients: A total of 57 pituitary tissue samples including 27 NFAs, 15 GH-producing adenomas with or without prolactin overproduction, and 15 normal pituitary glands were analyzed.
Results: Wee1 protein expression was decreased in NFAs and GH-producing tumors with or without prolactin production, but no change in mRNA expression was observed with qRT-PCR. A specific subset of five miRNAs revealed by in silico target prediction was significantly overexpressed in NFA samples; three miRs (miR-128a, miR-155, and miR-516a-3p) targeted the 3'-untranslated region of the Wee1 transcript, and exogenous overexpression of these miRs inhibited Wee1 protein expression and HeLa cell proliferation.
Conclusions: To our knowledge, this is the first report suggesting that regulation of Wee1 kinase by miRs may be linked to pituitary tumorigenesis.
Whyte E, Nezu M, Chik C, Tateno T Endocrinol Metab (Seoul). 2023; 38(6):631-654.
PMID: 37964483 PMC: 10764990. DOI: 10.3803/EnM.2023.1838.
Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.
Alli V, Yadav P, Suresh V, Jadav S ACS Omega. 2023; 8(23):20196-20233.
PMID: 37323408 PMC: 10268025. DOI: 10.1021/acsomega.3c01558.
Chen Z, Sun X, Kang Y, Zhang J, Jia F, Liu X Front Endocrinol (Lausanne). 2023; 13:1079777.
PMID: 36686480 PMC: 9846255. DOI: 10.3389/fendo.2022.1079777.
Montagne K, Furukawa K, Taninaka Y, Ngao B, Ushida T PLoS One. 2022; 17(12):e0275682.
PMID: 36538560 PMC: 9767356. DOI: 10.1371/journal.pone.0275682.
Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma.
Wu W, Cao L, Jia Y, Xiao Y, Zhang X, Gui S Cells. 2022; 11(18).
PMID: 36139495 PMC: 9496700. DOI: 10.3390/cells11182920.